Switch to:
More From Other Websites
Shire (SHPG) Rare Disease Drug Gets Fast Track Designation Mar 23 2017
XBiotech (XBIT) Catches Eye: Stock Moves Up 11.6% in Session Mar 23 2017
Valeant's (VRX) Glaucoma Candidate Gets PDUFA Date from FDA Mar 21 2017
Mylan Receives Tentative Approval from FDA for HIV Therapy Mar 21 2017
Alnylam's LDL-Lowering Drug Positive in Phase II Study Mar 20 2017
Zacks.com featured highlights: American Woodmark, Heska, OraSure Technologies, Pioneer Natural... Mar 20 2017
Alexion (ALXN) Licenses Artubus Technology for Rare Diseases Mar 17 2017
Shire's (SHPG) Cinryze Label Expanded for Pediatric Use Mar 16 2017
Endo's (ENDP) Opana ER's Risk Benefit Evaluated by FDA Mar 16 2017
Alimera Sciences, Inc. (ALIM) Looks Good: Stock Up 12.8% Mar 14 2017
Post Earnings Coverage as VWR Corp. Q4 2016 Results Outperformed Projections Mar 14 2017
Perrigo Launches First to Market OTC Equivalent of Rogaine Mar 09 2017
HESKA CORP Financials Mar 09 2017
Seattle Genetics (SGEN): FDA Lifts Hold on Trial of AML Drug Mar 08 2017
GlaxoSmithKline's Nucala Positive in Label Expansion Study Mar 07 2017
Heska Corp. :HSKA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 7, 2017 Mar 07 2017
Adaptimmune Therapeutics (ADAP) Jumps: Stock Rises 10.5% Mar 06 2017
HESKA CORP Files SEC form 10-K, Annual Report Mar 06 2017
Nabriva Therapeutics (NBRV) Catches Eye: Stock Gains 9.8% Mar 03 2017
Heska Corp.: Leads amongst peers with strong fundamentals Mar 01 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK